Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Novo Nordisk enlists Thermo Fisher as 2nd Wegovy contract manufacturer - Reuters

Published 08/23/2023, 11:32 AM
Updated 08/23/2023, 11:32 AM
© Reuters.  Novo Nordisk enlists Thermo Fisher as 2nd Wegovy contract manufacturer - Reuters

According to a Reuters report Wednesday, Novo Nordisk (NYSE:NVO) has enlisted Thermo Fisher Scientific (NYSE:TMO) as their second contract manufacturer for their highly sought-after weight-loss medication, Wegovy.

Sources told the publication that Thermo is responsible for filling the Wegovy injection pens at their factory located in Greenville, North Carolina.

The news has seen Thermo shares jump, hitting a high of $547.50 per share. The stock is currently trading at $542.20, up more than 2.8% in the session.

In May, Novo Chief Financial Officer Karsten Munk Knudsen revealed to Reuters that the company had signed up a second contract manufacturer in the US but did not disclose the identity of the company.

Novo is said to be rushing to increase the output of the drug to meet soaring demand in the US following production problems at a factory in Brussels, Belgium, operated by its first contract manufacturer, Catalent (NYSE:CTLT).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.